Immuno-Oncology Will Require Extensive Staff Training

Tony Hagen @oncobiz
Published: Monday, Jan 30, 2017
blood cells Immuno-oncology (I/O) drugs have the potential to improve the level of care in many respects, but they bring with them a host of problems related to implementation that require a completely new set of strategies, according to a white paper released by the Institute for Clinical Immuno-Oncology (ICLIO). High among these problems is the need for extensive staff training, because I/O is still a frontier of discovery and providers’ understanding of the many new drugs that have been approved is by no means complete.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: New Directions in Advanced Cutaneous Squamous Cell Carcinoma: Emerging Evidence of ImmunotherapyAug 13, 20191.5
Publication Bottom Border
Border Publication
x